Abstract
Background: Carbapenemase-producing Enterobacteriaceae (CPE) represents a global public health concern and systemic infections associated with OXA - 48 carbapenemase are increasingly being reported in Latin America. Here, we present the first 2 cases of systemic infections by OXA-48-Producing Klebsiella pneumoniae in Peru. A favorable clinical response was observed after targeted treatment with colistin as a backbone.
| Translated title of the contribution | Primeros casos clínicos de infecciones por Klebsiella pneumoniae productora de OXA-48 en Perú |
|---|---|
| Original language | English |
| Pages (from-to) | 379-382 |
| Number of pages | 4 |
| Journal | Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| State | Published - Nov 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Klebsiella Pneumoniae
- OXA-48, carbapenemases, Peru (Source: DeCSBIREME)
Fingerprint
Dive into the research topics of 'First Clinical Cases of OXA-48-Producing Klebsiella pneumoniae in Peru'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver